Open AccessDurvalumab Significantly Improves Survival in Biliary Tract Cancer
Author(s) -
Mark L. Fuerst
Publication year - 2022
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000821984.81516.4c
Subject(s) - gemcitabine , durvalumab , medicine , oncology , biliary tract , cisplatin , chemotherapy , cancer , biliary tract cancer , immunotherapy , gastroenterology , nivolumab